Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: Evidence for platelet hyperactivity and chronic inflammation

Diabetologia

Volumn 47, Issue 3, 2004, Pages 537-540

  Yngen, M ^a   Ostenson C G ^a   Hu, H ^a   Li, N ^a   Hjemdahl, P ^a   Wallen N H ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

Author keywords

C reactive protein; Endothelium; Inflammation; Microangiopathy; P selectin; Platelets; Soluble CD40 Ligand; Type 1 diabetes mellitus

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CD40 LIGAND; PADGEM PROTEIN; THROMBIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CELL FUNCTION; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; FEMALE; FLOW CYTOMETRY; GLYCEMIC INDEX; HUMAN; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION;

ADULT; BLOOD GLUCOSE; BLOOD PLATELETS; BLOOD PRESSURE; CD40 LIGAND; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; INFLAMMATION; MALE; P-SELECTIN; PLATELET AGGREGATION; REFERENCE VALUES; THROMBIN; TRIGLYCERIDES;

EID: 1842844422     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1352-4     Document Type: Article

References (10)

1. Biondi-Zoccai GG, Abbate A, Liuzzo G, Biasucci LM (2003) Atherothrombosis, inflammation, and diabetes. J Am Coll Cardiol 41:1071-1077
2. Laing SP, Swerdlow AJ, Slater SD et al. (2003) Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46:760-765
3. André P, Hartwell D, Hrachovinová I, Saffaripour S, Wagner DD (2000) Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 97:13835-13840
4. Burger PC, Wagner DD (2003) Platelet P-selectin facilitates atherosclerotic lesion development. Blood 101:2661-2666
5. Henn V, Slupsky JR, Gräfe M et al. (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591-594
6. Heeschen C, Dimmeler S, Hamm CW et al. (2003) Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 348:1104-1111
7. Varo N, Vicent D, Libby P et al. (2003) Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: A novel target of thiazolidinediones. Circulation 107:2664-2669
8. Schalkwijk CG, Poland DC, Dijk W van et al. (1999) Plasma concentration of C-reactive protein is increased in type 1 diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: Evidence for chronic inflammation. Diabetologia 42:351-357
9. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979
10. Alessandrini P, McRae J, Feman S, Fitzgerald GA (1988) Thromboxane biosynthesis and platelet function in type 1 diabetes mellitus. N Engl J Med 319:208-212